0001103021-21-000006.txt : 20210129
0001103021-21-000006.hdr.sgml : 20210129
20210129190521
ACCESSION NUMBER: 0001103021-21-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210127
FILED AS OF DATE: 20210129
DATE AS OF CHANGE: 20210129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Thomas B
CENTRAL INDEX KEY: 0001748462
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 21573519
MAIL ADDRESS:
STREET 1: BIODELIVERY SCIENCES INTERNATIONAL, INC.
STREET 2: 4131 PARKLAKE AVE SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_161196510268074.xml
FORM 4
X0306
4
2021-01-27
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001748462
Smith Thomas B
C/O BIODELIVERY SCIENCES INTL, INC.,
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
0
1
0
0
Chief Medical Officer
Stock Options (right to buy)
3.84
2021-01-27
4
A
0
287194
0
A
2031-01-26
Common Stock
287194.0
287194
D
Restricted Stock Units
0.0
2021-01-27
4
A
0
52083
0
A
2024-01-27
Common Stock
52083.0
52083
D
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2021.
The stock options were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024.
The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024.
Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
/s/ Thomas Smith, MD.
2021-01-29